1. Home
  2. GPCR vs OI Comparison

GPCR vs OI Comparison

Compare GPCR & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • OI
  • Stock Information
  • Founded
  • GPCR 2016
  • OI 1903
  • Country
  • GPCR United States
  • OI United States
  • Employees
  • GPCR N/A
  • OI N/A
  • Industry
  • GPCR
  • OI Containers/Packaging
  • Sector
  • GPCR
  • OI Consumer Discretionary
  • Exchange
  • GPCR Nasdaq
  • OI Nasdaq
  • Market Cap
  • GPCR 1.8B
  • OI 1.8B
  • IPO Year
  • GPCR 2023
  • OI N/A
  • Fundamental
  • Price
  • GPCR $27.03
  • OI $10.93
  • Analyst Decision
  • GPCR Buy
  • OI Buy
  • Analyst Count
  • GPCR 6
  • OI 8
  • Target Price
  • GPCR $85.67
  • OI $16.25
  • AVG Volume (30 Days)
  • GPCR 797.2K
  • OI 1.1M
  • Earning Date
  • GPCR 11-13-2024
  • OI 02-04-2025
  • Dividend Yield
  • GPCR N/A
  • OI N/A
  • EPS Growth
  • GPCR N/A
  • OI N/A
  • EPS
  • GPCR N/A
  • OI N/A
  • Revenue
  • GPCR N/A
  • OI $6,643,000,000.00
  • Revenue This Year
  • GPCR N/A
  • OI N/A
  • Revenue Next Year
  • GPCR N/A
  • OI N/A
  • P/E Ratio
  • GPCR N/A
  • OI N/A
  • Revenue Growth
  • GPCR N/A
  • OI N/A
  • 52 Week Low
  • GPCR $29.48
  • OI $10.08
  • 52 Week High
  • GPCR $62.74
  • OI $17.58
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 35.94
  • OI 25.84
  • Support Level
  • GPCR $30.81
  • OI $10.43
  • Resistance Level
  • GPCR $36.42
  • OI $11.93
  • Average True Range (ATR)
  • GPCR 2.10
  • OI 0.39
  • MACD
  • GPCR -0.15
  • OI -0.17
  • Stochastic Oscillator
  • GPCR 25.07
  • OI 8.13

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: